FORGOT YOUR DETAILS?

中美生物医药创新与资本高峰对话

us-china Biopharma
Innovation & Investment
Summit

october 22-23, 2018 - shanghai

reasons to join us in shanghai

China’s biotech scene has been exploding over the past 2 years. Chinese investors are not just pouring billions into new Asian startups, they’re also jumping into global syndicates backing a new generation of startups in the US and Europe as well.

This October, we’ll be bringing top industry players in China and the US to Shanghai for the inaugural run of the US-China Biopharma Innovation and Investment Summit. For US companies, this is a chance to explore the most important emerging healthcare market in the world, with a forecast on drug innovation and a chance to meet potential partners. And you’ll hear directly from a group of headliners on both sides of the Pacific on the most important developments you need to be aware of, with a special focus on the regulatory scene.

This is a crucial year for US-China biopharma and you won't want to miss this 2-day summit we're planning for you at the Shanghai Four Seasons, located in Pudong in the ultra-modern 21st Century Tower.

Featuring

Samantha Du

Chairman & CEO
Zai Lab

John Oyler

Founder & CEO
BeiGene

Leon Chen

CEO & Founding Partner
6 Dimensions Capital

Fred Cohen

Co-Founder
Vida Ventures

Faheem Hasnain

Executive Chairman
Gossamer Bio

Jonathan Wang

Founding Partner
OrbiMed Asia

Vivek Ramaswamy

CEO & Founder
Roivant Sciences

Nisa Leung

Managing Partner
Qiming Venture Partners

Yao-Chang Xu

Founder & CEO
Abbisko Therapeutics

Dechao Yu

President & CEO
Innovent

Brad Loncar

CEO
Loncar Investments

John Carroll

Founder & Editor
Endpoints News

Jianhua Jiang

CEO
PharmCube

Liu Weimin

Partner
Eight Roads

Dajun Yang

CEO
Ascentage Pharma

Guoliang Yu

Founder
CBT Pharmaceuticals

Weichang Zhou

CTO
WuXi Biologics

Weiguo Su

CSO
Hutchison MediPharma

Lu Huang

Managing Director
Morningside VC

Yibo Cao

Managing Director
Sequoia Capital China

Dr. John E. Connolly

Chief Scientific Officer
Tessa Therapeutics Pte Ltd

Karen Liu

Founding partner
3E Bioventures Capital

Dr George Syrmalis

Founder & Group CEO
The iQ Group Global

Harry Simeonidis

President - Glucose Biosensor Systems (GC)

Shuqian Jing

Founder, Chairman and CEO - GmaxBio

Arsalan Arif

Founder & CEO
Endpoints News

sponsors

SPONSORSHIP PACKAGES AVAILABLE

Mike Peck - VP, Partnerships at Endpoints News - mike@endpointsnews.com

TRANSPACIFIC PARTNER

Table meeting space on both days

Materials distributed to 170k+ WeChat subscribers and 60k+ Xueqiu followers

Coverage in Chinese media before and after BIIS

Distribute company plan to Chinese investors database

PRESENTING SPONSORSHIP

5+ minute presentation slot

Advertising in Endpoints News and Pharmcube

Materials and logo onsite

summit agenda

monday, October 22

     

KEYNOTES

  • US/China Biopharma Review
  • China's New Regulatory Landscape
  • Chinese Innovation from Bench to Bedside
  • ... more TBD
     

Buffet Lunch

     

Fireside Chats

     

Company Roadshows

     

Panels

  • Innovation
    • Focusing on the R&D "gap"
    • Cancer pipeline in China
  • Transpacific dealmaking
    • Best and worst approaches to inking a deal in China
    • What do US executives want from China deals?
     

Dinner and cocktails

tuesday, October 23

     

KEYNOTES

  • US VC Landscape and Implications for Chinese Ventures
  • Rise of China Biopharma and Its Unique Dynamics
  • The New Rules for Listing on HKEX
  • ... more TBD
     

Buffet Lunch

     

Fireside Chats

     

Company Roadshows

     

Panels

  • Investment and Exits
    • The new China biotech investors - Top VC and PE players
    • Pattern analysis on US financing trends and implications for China
    • IPOs in China and the US
  • New Technology
    • Gene editing - a special focus on leading programs 
    • AI in the drug development process

Agenda is updated frequently; bookmark for the latest info

frequently asked questions

Yes, PharmCube will furnish individual letters on official letter upon request to confirmed registrants. Please enter your details here.

Your ticket includes admission to the entire summit, including a lunch buffet and tea and snacks on both days, and dinner and cocktails on the first night.

You can use this form (PDF link) for guaranteed rates at the Four Seasons in Pudong. Orders must be confirmed by October 7.

If you are a Chinese company wishing to present, please contact Richard Wang at PharmCube: wangdong@pharmcube.com
For all other brand and content sponsorship opportunities, contact Mike Peck, the VP of Partnerships at Endpoints News: mike@endpointsnews.com

venue

Rising high above the Pudong Lujiazui business district, this art-deco–inspired Hotel sits in the gleaming 21st Century Tower, surrounded by iconic skyscrapers and bustling city streets lined with luxury shopping, restaurants and prestigious financial centres.

us-china Biopharma Innovation & Investment Summit

OCTOBER 22-23, 2018 - SHANGHAI

TOP